July 9, 2018 — For the most part, microcap stocks don’t receive much attention from the Wall Street analysts because they have little incentive to cover them. Analysts tend to report on stocks their banks and brokers do business with or are likely to engage with the near future.
When investing in microcap companies an investor should pay attention to global trends and any associated risk. Determining what sectors of the economy should see growth in the near future is important research.
These microcap companies have explosive features and futures that look for big upside potential:
APT Systems, Inc. (OTCPINK: APTY); Drone USA, Inc. (OTCQB: DRUS); MariMed Inc. (OTCQB: MRMD); Vitality Biopharma, Inc. (OTCQB: VBIO); Creative Medical Technology Holdings, Inc. (OTCQB: CELZ).
APT Systems Inc. (OTCPINK: APTY)
Market Cap: $1.74M, current share price: $.005
APT Systems Inc. is a small cap company that specializes in the creation of financial platforms and innovative stock research tools inside Intuitrader. They have launched dedicated charting apps under their brand KenCharts and intend to expand into tracking cryptocurrency charts. It would seem the excitement level in both fintech and cryptocurrencies is dwindling a bit and this is a good thing. There was far too much hype and now is the time to look for companies with solid Blockchain plans like APTY to step out. Management is planning to launch four platforms for its members, starting with Verifundr (escrow and payments) followed by their coining interchange to support SperaSM (a unique stable coin). APT Systems has joined with industry experts and advisors to deliver on this business plan strategically and quickly. APT Systems, Inc. and its CEO are committed to delivering on its business plan while also purposefully acquiring other compatible financial businesses, for its subsidiaries like Snapt Games, which demonstrate strong growth potential.
Drone USA, Inc. (OTCQB: DRUS)
Market Cap: $1.26M, current share price: $.01
Drone USA, Inc., is a technology company, focusing on the research, design, development, testing, manufacture, distribution, export, and integration of advanced low altitude unmanned aerial vehicles systems, services, and products. It offers quadcopter and fixed-wing unmanned aerial vehicles to government and commercial markets. The company, through its subsidiary, HowCo Distributing Co., also provides product procurement, distribution, and logistics services to the United States Department of Defense and Defense Logistics Agency. In addition, it provides drone operator training services; and licensed piloted services, such as search and rescue, utility inspection, real estate marketing, construction, engineering, and agriculture. Further, the company offers spare and replacement parts to various federal government agencies, the U.S. military prime contractors, and commercial customers worldwide.
MariMed Inc. (OTCQB: MRMD)
Market Cap: $568.77M, current share price: $2.94
MariMed Inc. is an industry leader in the design, development, operation, funding, and optimization of medical cannabis cultivation, production, and dispensary facilities. MariMed’s team has developed state-of-the-art, regulatory-compliant legal cannabis facilities in multiple states. These facilities are models of excellence in horticultural principals, cannabis production, product development, and dispensary operations. MariMed is on the forefront of precision dosed cannabis medicine for the treatment of specific medical conditions. MariMed branded products are being licensed and distributed in legal cannabis states across the country.
Vitality Biopharma, Inc. (OTCQB: VBIO)
Market Cap: $48.74M, current share price: $2.00
Vitality Biopharma is developing proprietary cannabinoid pharmaceuticals for treatment of serious neurological and inflammatory disorders. Vitality’s targeted prodrug technology enables delivery of cannabinoids to the site of disease while reducing or eliminating psychoactivity.
Creative Medical Technology Holdings, Inc. (OTCQB: CELZ)
Market Cap: $33.87M, current share price: $.05
Creative Medical is engaged in stem cell research and applications for use to treat male and female sexual dysfunction, infertility and related issues. It holds a patent for its erectile dysfunction (“ED”) treatment and was granted a license by Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, a non-profit biomedical research and education institute (“LABIOMED”), for the infertility treatment. It has also filed a patent application focused on physical manifestations of female sexual arousal disorder, as an extension of the work with stem cell therapies for ED. Following testing of its ED treatment, Creative Medical intends to market treatment kits to physicians for use with their patients suffering from ED. During first quarter 2016, it commenced a 15-month clinical trial study being conducted at UCLA by LABIOMED on the efficacy and safety of the ED treatment. The study involves testing on 40 subjects.
Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. ACR Communication, LLC, which owns Microcapspeculators.com, is not registered with FINRA or any other financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. ACR Communication, LLC [and/or] Microcapspeculators.com does not have a position in the securities mentioned herein and may increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice. ACR Communication LLC, which owns Microcapspeculators.com, is compensated for its services in the form of cash-based compensation or in equity in the companies it writes about, or a combination of the two. ACR Communication, LLC has been compensated one thousand dollars cash for this article and three thousand dollars total by Regal Consulting, LLC, for APTY. APTY and Regal Consulting, LLC were given an opportunity to edit information included in this article. This article is based solely on public information and the opinions of ACR Communication, LLC, which believes the news commentary to include accurate and complete information. ACR Communication, LLC, will not buy or sell any shares in stocks contained within this article for forty eight hours after this article’s distribution.
For Full Legal Disclaimer Click Here
Company Name: Microcap Speculators
Contact Person: Media Manager
Email: [email protected]
Country: United States